Clinical Professor Paul Harnett

Clinical Professor
Medicine, Westmead Clinical School

C24 - Westmead Hospital
The University of Sydney
NSW 2006 Australia

T: +61 2 9845 6432
F: +61 2 9891 6035

On this page

Grants | Publications


Current national competitive grants*


Molecular markers of relapse and treatment response in ovarian cancer
de Fazio A, Harnett P, Bowtell D
NHMRC Project Grants ($521,599 over 3 years)

* Grants administered through the University of Sydney


2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009


  • Lei, Y., Henderson, B., Emmanuel, C., Harnett, P., Defazio, A. (2015), Inhibition of ANKRD1 sensitizes human ovarian cancer cells to endoplasmic reticulum stress-induced apoptosis. Oncogene. 34(4), 485-495. [Abstract]


  • Emmanuel, C., Chiew, Y., George, J., Etemadmoghadam, D., Sharma, R., Russell, P., Kennedy, C., Fereday, S., Hung, J., Galletta, L., Hogg, R., Wain, G., Brand, A., Balleine, R., Anglesio, M., MacConaill, L., Palescandolo, E., Hunter, S., Campbell, I., Dobrovic, A., Wong, S., Do, H., Clarke, C., Harnett, P., Bowtell, D., deFazio, A. (2014), Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS-pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. Clinical Cancer Research. 20(24), 6618-6630. [Abstract]
  • Gupta, S., Taylor, N., Selvakumar, D., Harnett, P., Wilcken, N., Lee, C. (2014), Retrospective Imaging Audit and Cost Analysis of Medical Oncology Inpatients Admitted to Westmead Hospital. Internal Medicine Journal. 44(12a), 1235-1239. [Abstract]
  • Hedditch, E., Gao, B., Russell, A., Lu, Y., Emmanuel, C., Beesley, J., Johnatty, S., Chen, X., Harnett, P., George, J., Williams, R., Flemming, C., Lambrechts, D., Despierre, E., Lambrechts, S., Vergote, I., Karlan, B., Lester, J., Orsulic, S., Walsh, C., Fasching, P., Beckmann, M., Ekici, A., Hein, A., Matsuo, K., Hosono, S., Nakanishi, T., Yatabe, Y., Pejovic, T., Bean, Y., Heitz, F., Harter, P., du Bois, A., Schwaab, I., Hogdall, E., Kjaer, S., Jensen, A., Hogdall, C., Lundvall, L., Engelholm, S., Brown, B., Flanagan, J., Metcalf, M., Siddiqui, N., Sellers, T., Fridley, B., Cunningham, J., Schildkraut, J., Iversen, E., Weber, R., Berchuck, A., Goode, E., Bowtell, D., Chenevix-Trench, G., deFazio, A., Norris, M., MacGregor, S., Haber, M., Henderson, M. (2014), ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer. Journal of the National Cancer Institute. 106(7), dju149. [Abstract]
  • Ojaimi, S., Harnett, P., Fulcher, D. (2014), Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels. Journal of Allergy and Clinical Immunology. In Practice. , 105-106. [Abstract]
  • Gao, B., Russell, A., Beesley, J., Chen, X., Healey, S., Henderson, M., Wong, M., Emmanuel, C., Galletta, L., Johnatty, S., Bowtell, D., Haber, M., Norris, M., Harnett, P., Chenevix-Trench, G., Balleine, R., Defazio, A. (2014), Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer. Scientific Reports. 4, 4669. [Abstract]


  • Carus, A., Gurney, H., Gebski, V., Harnett, P., Hui, R., Kefford, R., Wilcken, N., Ladekarl, M., von der Maase, H., Donskov, F. (2013), Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia. Journal of Translational Medicine. 11(1), 189. [Abstract]
  • Stoodley, P., Richards, D., Boyd, A., Hui, R., Harnett, P., Meikle, S., Byth, K., Stuart, K., Clarke, J., Thomas, L. (2013), Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: A comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months. European Journal of Cancer. 49(16), 3396-3403. [Abstract]
  • Stoodley, P., Richards, D., Boyd, A., Hui, R., Harnett, P., Meikle, S., Clarke, J., Thomas, L. (2013), Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy. European Heart Journal Cardiovascular Imaging. 14(3), 228-234. [Abstract]


  • Cowin, P., George, J., Fereday, S., Loehrer, E., Van Loo, P., Cullinane, C., Etemadmoghadam, D., Ftouni, S., Galletta, L., Anglesio, M., Hendley, J., Bowes, L., Sheppard, K., Christie, E., Pearson, R., Harnett, P., Heinzelmann-Schwarz, V., Friedlander, M., McNally, O., Quinn, M., Campbell, P., Defazio, A., Bowtell, D. (2012), LRP1B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemotherapy Resistance to Liposomal Doxorubicin. Cancer Research. 72(16), 4060-4073. [Abstract]
  • Harnett, P. (2012), All pains are equal, but some seem more urgent than others. Lancet. 380(9836), 28. [Abstract]
  • Harnett, P., Kerridge, I., Jordens, C., Hobbs, K., Mason, C., Morrell, B. (2012), Beyond evidence: reappraising use of CA-125 as post-therapy surveillance for ovarian cancer. Medical Journal of Australia. 196(7), 440-441. [Abstract]
  • Cohen, S., Reid, S., Pixton, S., Harnett, P., Condous, G. (2012), Choriocarcinoma of the lung masquerading as a persisting pregnancy of unknown location (PUL). Australian and New Zealand Journal of Obstetrics and Gynaecology. , 211-212. [Abstract]
  • Morrell, B., Jordens, C., Kerridge, I., Harnett, P., Hobbs, K., Mason, C. (2012), The perils of a vanishing cohort: a study of social comparisons by women with advanced ovarian cancer. Psycho-Oncology. 21(4), 382-391. [Abstract]


  • Stoodley, P., Richards, D., Hui, R., Boyd, A., Harnett, P., Meikle, S., Clarke, J., Thomas, L. (2011), Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy. European Journal of Echocardiography. 12(12), 945-952. [Abstract]
  • Pharoah, P., Palmieri, R., Ramus, S., Gayther, S., Andrulis, I., Anton-Culver, H., Antonenkova, N., Antoniou, A., Goldgar, D., Beattie, M., Beckmann, M., Birrer, M., Bogdanova, N., Bolton, K., Brewster, W., Brooks-Wilson, A., Brown, R., Butzow, R., Caldes, T., Caligo, M., Campbell, I., Chang-Claude, J., Chen, Y., Cook, L., Couch, F., Cramer, D., Cunningham, J., Despierre, E., Doherty, J., Dörk, T., Dürst, M., Eccles, D., Ekici, A., Easton, D., Fasching, P., de Fazio, A., Fenstermacher, D., Flanagan, J., Fridley, B., Friedman, E., Gao, B., Sinilnikova, O., Gentry-Maharaj, A., Godwin, A., Goode, E., Goodman, M., Gross, J., Hansen, T., Harnett, P., Rookus, M., Heikkinen, T., Hein, R., Høgdall, C., Høgdall, E., Iversen, E., Jakubowska, A., Johnatty, S., Karlan, B., Kauff, N., Kaye, S., Chenevix-Trench, G., Kelemen, L., Kiemeney, L., Kjaer, S., Lambrechts, D., Lapolla, J., Lázaro, C., Le, N., Leminen, A., Leunen, K., Levine, D., Lu, Y., Lundvall, L., Macgregor, S., Marees, T., Massuger, L., McLaughlin, J., Menon, U., Montagna, M., Moysich, K., Narod, S., Nathanson, K., Nedergaard, L., Ness, R., Nevanlinna, H., Nickels, S., Osorio, A., Paul, J., Pearce, C., Phelan, C., Pike, M., Radice, P., Rossing, M., Schildkraut, J., Sellers, T., Singer, C., Song, H., Stram, D., Sutphen, R., Lindblom, A., Terry, K., Tsai, Y., van Altena, A., Vergote, I., Vierkant, R., Vitonis, A., Walsh, C., Wang-Gohrke, S., Wappenschmidt, B., Wu, A., Ziogas, A., Berchuck, A., Risch, H. (2011), The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing. Clinical Cancer Research. 17(11), 3742-3750. [Abstract]
  • Emmanuel, C., Gava, N., Kennedy, C., Balleine, R., Sharma, R., Wain, G., Brand, A., Hogg, R., Etemadmoghadam, D., George, J., Birrer, M., Clarke, C., Chenevix-Trench, G., Bowtell, D., Harnett, P., Defazio, A. (2011), Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis. PLoS One. 6(3), e17617. [Abstract]


  • Jordens, C., Morrell, B., Harnett, P., Hobbs, K., Mason, C., Kerridge, I. (2010), Cancergazing? CA125 and post-treatment surveillance in advanced ovarian cancer. Social science & medicine (1982). 71(9), 1548-56. [Abstract]
  • Dear, R., Gao, B., Harnett, P. (2010), Recurrent ovarian cancer: Treatment with pegylated liposomal doxorubicin; a Westmead Cancer Care Centre experience. Asia Pacific Journal of Clinical Oncology. 6(1), 66-73. [Abstract]


  • Etemadmoghadam, D., deFazio, A., Beroukhim, R., Mermel, C., George, J., Getz, G., Tothill, R., Okamoto, A., Raeder, M., Harnett, P., Lade, S., Akslen, L., Tinker, A., Locandro, B., Alsop, K., Chiew, Y., Traficante, N., Fereday, S., Johnson, D., Fox, S., Sellers, W., Urashima, M., Salvesen, H., Meyerson, M., Bowtell, D. (2009), Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. Clinical Cancer Research. 15(4), 1417-1427. [Abstract]